While cancer therapies are getting more personalized (and expensive), patient outcomes don’t seem to improve along the same trajectory and SynDevRx believes to know why that is. According to the company’s research the answer lies in the way that obesity, diabetes, and other forms of metabolic dysfunction accelerate tumor growth and metastasis, making at least 13 common types of cancer much more…
Nuvo Group, the private company commercializing INVU by Nuvo, an FDA-cleared, prescription-initiated, remote pregnancy monitoring platform, recently announced that it has filed a 510(k) notice with the U.S. Food and Drug Administration (FDA) to add a new uterine activity module that provides capability for remote monitoring of maternal uterine activity (MUA). INVU has already received FDA clearance for remote monitoring and measurement of fetal and…
Tia recently announced the opening of its second location in Los Angeles. While in-person care will officially start in March 2021, virtual care is available as of now. Tia is known for championing the concept of “Whole Person Health” and aims to recreate a healthcare system that was designed for specialties, body parts, and treating sickness. The company announced the close of…
Last week Mae, a maternal health tech startup focused on providing critical resources to Black expectant mothers in the U.S. announced their soft-launch. ´The platform features a free birth planning tool that anyone can access, and free 15 minute consults with doulas for interested expectant mothers. The platform’s founder Maya Hardigan explains: “Mae is a digital health platform that elevates the standard of care for Black…
To study perinatal depression in women – before and after childbirth – and possible new treatments, The Feinstein Institutes for Medical Research has been awarded more than $4 million in multi-year grants. The research will be led by Kristina Deligiannidis, MD, associate professor at the Feinstein Institutes’ Institute of Behavioral Science. The Feinstein Institutes for Medical Research is the research arm of Northwell Health, the largest health care…
Pregna has recently announced the launch of its cryotherapy device CryoPop. The product was developed by Jhpiego with an objective of making treatment of cervical pre-cancerous lesions accessible to all. Pregna is the exclusive global commercialising partner for the device. “Cervical cancer is one of the most common and fatal forms of cancer in women worldwide, with about 85% of these deaths occurring in low and…
Every Thursday we send out a curated newsletter on “all things femtech and women’s health innovation”. This is the latest edition. If you’re interested in subscribing, you can do so at the bottom of this page. Highlights BioAesthetics raises a $5M Series A to commercialize NACgraft, a regenerative nipple graft for breast cancer survivors; Period underwear company Thinx gets into activewear; Willow release their third generation breast…
Runway Growth Capital, a provider of growth loans to both venture and non-venture backed companies seeking an alternative to raising equity, announced today the closing of a senior secured term loan of $50 million to Gynesonics, a healthcare company focused on advancing women’s health by developing minimally invasive, incision-free, uterus-preserving, transcervical technologies for diagnostic and therapeutic applications. Gynesonics has developed and has received FDA clearance for…
